CIM to Launch CIMAvax on the International Market
After 25 long years of studies and innumerable clinical trials which took place in Canada, the United Kingdom, Malaysia, China and at the Roswell Park Cancer Institute in the United States, the Center for Molecular Immunology of Cuba (CIM) has revealed it is f... More »